NO20034419L - Antifungalt preparat med forbedret biotilgjengelighet - Google Patents

Antifungalt preparat med forbedret biotilgjengelighet

Info

Publication number
NO20034419L
NO20034419L NO20034419A NO20034419A NO20034419L NO 20034419 L NO20034419 L NO 20034419L NO 20034419 A NO20034419 A NO 20034419A NO 20034419 A NO20034419 A NO 20034419A NO 20034419 L NO20034419 L NO 20034419L
Authority
NO
Norway
Prior art keywords
improved bioavailability
antifungal drug
antifungal
drug
bioavailability
Prior art date
Application number
NO20034419A
Other languages
English (en)
Other versions
NO20034419D0 (no
Inventor
Stefan Sharpe
Joel Sequeira
David Harris
Shashank Mahashabde
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23076102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20034419(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO20034419D0 publication Critical patent/NO20034419D0/no
Publication of NO20034419L publication Critical patent/NO20034419L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647—Triazoles; Hydrogenated triazoles
    • A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20034419A 2001-04-03 2003-10-02 Antifungalt preparat med forbedret biotilgjengelighet NO20034419L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28113901P 2001-04-03 2001-04-03
PCT/US2002/010093 WO2002080678A1 (en) 2001-04-03 2002-04-01 Antifungal composition with enhanced bioavailability

Publications (2)

Publication Number Publication Date
NO20034419D0 NO20034419D0 (no) 2003-10-02
NO20034419L true NO20034419L (no) 2003-12-02

Family

ID=23076102

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034419A NO20034419L (no) 2001-04-03 2003-10-02 Antifungalt preparat med forbedret biotilgjengelighet

Country Status (18)

Country Link
US (2) US20030055067A1 (no)
EP (2) EP1372394A1 (no)
JP (2) JP4308902B2 (no)
KR (1) KR100607742B1 (no)
CN (1) CN100415234C (no)
AR (1) AR033096A1 (no)
AU (1) AU2002257104B2 (no)
BR (1) BR0208626A (no)
CA (1) CA2443089C (no)
HU (1) HUP0400856A3 (no)
MX (1) MXPA03009021A (no)
NO (1) NO20034419L (no)
NZ (1) NZ528363A (no)
PE (1) PE20020994A1 (no)
PL (1) PL212985B1 (no)
TW (1) TWI311464B (no)
WO (1) WO2002080678A1 (no)
ZA (1) ZA200307684B (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
CN1558755A (zh) 2001-09-26 2004-12-29 ���ع��ʹ�˾ 通过分散和除去溶剂或液相制备亚微米大小的纳米颗粒
EP1761247A1 (en) * 2004-05-28 2007-03-14 Schering Corporation Injectable pharmaceutical suspension comprising posaconazole
US20060160823A1 (en) * 2004-05-28 2006-07-20 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
MX2008015275A (es) * 2006-05-30 2009-02-06 Elan Pharma Int Ltd Formulaciones de posaconazol en nanoparticulas.
PL2037914T3 (pl) 2006-06-14 2014-04-30 Intervet Int Bv Zawiesina zawierająca karbaminian benzoimidazolu i polisorbat
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
FR2910323A1 (fr) * 2006-12-26 2008-06-27 Virbac Sa Sa Composition liquide anhydre destinee a etre incorporee a l'eau de boisson des animaux d'elevage.
DE102008004893A1 (de) * 2008-01-17 2009-07-23 Add Technologies Ltd. Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
EP2278957A2 (en) * 2008-04-15 2011-02-02 Schering Corporation Oral pharmaceutical compositions in a solid dispersion comprising preferably posaconazole and hpmcas
CN104983701A (zh) * 2008-04-15 2015-10-21 默沙东公司 优选含有泊沙康唑和hpmcas的固体分散体形式的口服药物组合物
EP2130540A1 (en) 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
EP2451805A1 (en) 2009-07-09 2012-05-16 Sandoz AG A crystalline form of posaconazole
US9073904B2 (en) 2010-05-19 2015-07-07 Sandoz Ag Preparation of posaconazole intermediates
BR112012029225B1 (pt) 2010-05-19 2020-10-27 Sandoz Ag processo para a preparação de um composto quiral, composto quiral e uso de um composto quiral
CN102906087B (zh) 2010-05-19 2016-03-23 桑多斯股份公司 制备手性三唑酮的方法
US9206146B2 (en) 2010-05-19 2015-12-08 Sandoz Ag Purification of posaconazole and of posaconazole intermediates
WO2012172015A1 (en) 2011-06-16 2012-12-20 Sandoz Ag Process for the preparation of a chiral compound
US20150164890A1 (en) 2012-06-14 2015-06-18 Sandoz Ag Pharmaceutical compositions comprising crystalline posaconazole
CN107001343B (zh) 2014-12-05 2020-12-11 普尔莫赛德有限公司 抗真菌的化合物
WO2016185225A1 (en) 2015-05-21 2016-11-24 Pulmocide Limited Antifungal 4-(4-(4-(((3r,5r)-5-((1 h -1,2,4-triazol-1 -yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)- 3-methylphenyl)piperazin-1 -yl )-n -(2-h yd roxycyc lo h exyl) b e nzam i d e, or a pharmaceutically acceptable salt thereof.
CN105030668B (zh) * 2015-06-26 2018-03-27 济川药业集团有限公司 泊沙康唑口服混悬剂及其制备方法
CN106333925B (zh) * 2015-07-10 2019-06-18 上海美悦生物科技发展有限公司 一种泊沙康唑液体混悬剂及其制备方法
JP6803923B2 (ja) 2015-12-30 2020-12-23 エヌキューピー １５９８，リミテッド 金属酵素阻害化合物
CN106389390A (zh) * 2016-06-30 2017-02-15 重庆华邦制药有限公司 泊沙康唑涂膜剂及其制备方法
CN107625729A (zh) * 2017-09-29 2018-01-26 重庆华邦制药有限公司 泊沙康唑口服混悬液及其制备方法
CN110507609B (zh) * 2018-05-21 2021-09-17 上海医药工业研究院 泊沙康唑口服混悬剂的制备方法
GB201917867D0 (en) 2019-12-06 2020-01-22 Pulmocide Ltd Polymorphs
AU2021272730A1 (en) * 2020-05-12 2022-12-08 Cellix Bio Private Limited Process for the preparation salts of triazole compounds

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533254A (en) 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5552160A (en) 1991-01-25 1996-09-03 Nanosystems L.L.C. Surface modified NSAID nanoparticles
AU642066B2 (en) 1991-01-25 1993-10-07 Nanosystems L.L.C. X-ray contrast compositions useful in medical imaging
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5661151A (en) 1993-12-21 1997-08-26 Schering Corporation Tetrahydrofuran antifungals
ZA9410142B (en) * 1993-12-21 1996-05-02 Schering Corp Tetrahydrofuran antifungals
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5580579A (en) * 1995-02-15 1996-12-03 Nano Systems L.L.C. Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
CA2238048A1 (en) * 1995-11-20 1997-05-29 Hiromasa Okada Antifungal composition
US5834472A (en) * 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
US5846971A (en) 1996-06-28 1998-12-08 Schering Corporation Oral antifungal composition
CA2289618A1 (en) * 1997-05-14 1998-11-19 Shin-Ichi Yasueda Aqueous suspension preparations with excellent redispersibility
ES2216517T3 (es) 1998-05-29 2004-10-16 Skyepharma Canada Inc. Composiciones de microcapsulas termoprotegidas y procedimiento para su esterilizacion terminal con vapor.
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug

Also Published As

Publication number Publication date
ZA200307684B (en) 2005-03-30
KR100607742B1 (ko) 2006-08-01
CA2443089C (en) 2011-11-01
BR0208626A (pt) 2004-03-09
HUP0400856A2 (hu) 2004-08-30
EP2090165A2 (en) 2009-08-19
CN100415234C (zh) 2008-09-03
CA2443089A1 (en) 2002-10-17
MXPA03009021A (es) 2004-02-12
PE20020994A1 (es) 2002-11-01
PL363965A1 (en) 2004-11-29
NO20034419D0 (no) 2003-10-02
US20110244004A1 (en) 2011-10-06
JP4308902B2 (ja) 2009-08-05
JP2008120836A (ja) 2008-05-29
KR20030087052A (ko) 2003-11-12
HUP0400856A3 (en) 2012-09-28
AR033096A1 (es) 2003-12-03
EP1372394A1 (en) 2004-01-02
PL212985B1 (pl) 2012-12-31
AU2002257104B2 (en) 2006-02-09
JP2004527525A (ja) 2004-09-09
WO2002080678A1 (en) 2002-10-17
US20030055067A1 (en) 2003-03-20
TWI311464B (en) 2009-07-01
US8263600B2 (en) 2012-09-11
CN1499930A (zh) 2004-05-26
NZ528363A (en) 2005-04-29
EP2090165A3 (en) 2012-03-28

Similar Documents

Publication Publication Date Title
NO20034419L (no) Antifungalt preparat med forbedret biotilgjengelighet
NO20033143D0 (no) Farmasoytisk preparat
NO20034026D0 (no) Nytt preparat
NO20030418L (no) Nytt farmasöytisk preparat
NO20035208D0 (no) Nytt vaksine preparat
DK3210637T3 (da) Infusionssæt
DE50002776D1 (de) Fungizide wirkstoffkombinationen
DK1383560T4 (da) Infusionssæt
NO20033203L (no) Terapeutiske heterocykliske forbindelser
ATE432008T1 (de) Repellentmittel
NO20052239D0 (no) Fast preparat
NO20025805D0 (no) Farmasöytisk preparat
NO20034695L (no) Nytt preparat
NO20015149L (no) Nytt farmasöytisk preparat
DE50102752D1 (de) Fungizide wirkstoffkombinationen
NO20033829D0 (no) Antiviralt preparat
NO20015148L (no) Nytt farmasöytisk preparat
EP1445094A4 (en) LIGHT PROTECTION
DE50304722D1 (de) Fungizide Wirkstoffkombinationen
NO20040732L (no) Slagmatte for golf
DE50007895D1 (de) Fungizide wirkstoffkombinationen
NO20015104L (no) Nytt farmasöytisk preparat
NO20060375L (no) Famasoytisk preparat
NO20015105D0 (no) Nytt farmasöytisk preparat
NO20023392D0 (no) Preparat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP AND DOHME CORP., US

Free format text: NEW ADDRESS: 126 EAST LINCOLN AVENUE, US-NJ07065 RAHWAY

FC2A Withdrawal, rejection or dismissal of laid open patent application